CSI’s orbital atherectomy system debuts in Canada
Cardiovascular Systems, Inc. (CSI), a Minnesota-based healthcare technology company focused on treating peripheral artery disease and coronary artery disease (CAD), announced that patients in Canada have been treated with its Diamondback 360 Coronary Orbital Atherectomy System for the first time.
Sanjog Kalra, MD, an interventional cardiologist at Toronto General Hospital, performed the procedures.
“Patients with calcific CAD can have poor clinical outcomes unless optimally treated,” Kalra said in a prepared statement. “Revascularization for these patients requires interventionalists to fully prepare vessels for stenting so that full stent expansion is achieved. We know that perfect stent results lead to the best outcomes. Achieving optimal vessel preparation in heavily calcified coronary arteries is amongst my most challenging procedures. CSI’s orbital atherectomy technology enables effective calcium modification to facilitate full stent expansion.”
“The introduction of this device gives physicians in Canada an effective treatment option for this difficult-to-treat patient population,” added Scott Ward, CSI’s chairman, president and CEO.
Back in February, CSI announced that patients in Europe had been treated with the Diamondback 360 system for the first time.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.